In agreement with our findings, a recent study after evaluation of leukemia and various solid tumors including prostate, colorectal, breast, and liver cancers, also identified TOX methylation as important biomarker specifically for breast cancer [10]. The gene discussed is TOX; the disease is breast cancer.